US to approve $2.8B sale of 40,000 heavy bombs to Israel

3 min read
Source: Al Jazeera
US to approve $2.8B sale of 40,000 heavy bombs to Israel
Photo: Al Jazeera
TL;DR

The Trump administration is preparing to approve a $2.8 billion arms sale to Israel, including 40,000 2,000-pound bombs, funded largely by US taxpayers. The package, which includes Mk84s and BLU-117s, has been informally notified to Congress but faces bipartisan opposition. Critics argue the weapons exacerbate civilian casualties in Gaza, while the administration cites strategic necessity amid depleted US stockpiles from the Iran conflict.

Key points

  • The proposed deal values 40,000 2,000-pound bombs at $2.8 billion, with the majority paid through the Foreign Military Financing program.
  • The package consists of 20,000 Mk84 general-purpose bombs and 20,000 BLU-117 bombs, some of which can be fitted with precision-guidance kits.
  • Congress has been informally notified of the sale, but it is not yet final, and the State Department has not officially confirmed the transaction.
  • The Biden administration previously paused the delivery of these specific munitions in 2024 due to concerns over civilian casualties, a pause Trump reversed upon taking office.
  • A Pentagon report indicates US munition stockpiles are depleted due to the war on Iran, creating supply chain bottlenecks that the new sale aims to address.

Background

This sale follows a series of recent arms transfers, including a $6.67 billion package approved in January 2026 and a nearly $3 billion sale in 2025 that bypassed standard congressional review. The current conflict in Gaza, which began in October 2023, has resulted in over 73,000 Palestinian deaths according to local health authorities. The US has also recently engaged in military operations against Iran, further straining its defense inventory.

How outlets are covering it

Al Jazeera emphasizes the humanitarian impact, noting that 2,000-pound bombs have caused mass casualties and 'evaporation' of victims in Gaza, and frames the sale as part of a 'genocidal war.' NBC News and The New York Times focus on the financial scale and the bipartisan political backlash, highlighting that the sale is funded by US taxpayers and faces potential blockage from Democrats. The Washington Post frames the sale as the largest in years, noting it sets a political test for Democrats regarding their stance on military aid to Israel. All sources agree the deal is not yet final and has only been informally briefed to lawmakers.

Why it matters

The sale signals continued US military support for Israel despite international criticism and declining public approval ratings for the US-Iran conflict. It raises questions about the sustainability of US defense stockpiles and the ethical implications of funding weapons used in densely populated areas, potentially influencing future congressional oversight of foreign military financing.

What to watch

Congress will formally review the sale, with some lawmakers, including Senator Chris Van Hollen, vowing to block it. The State Department is expected to formally notify Congress once the sale is finalized. Israel may continue using these munitions in Gaza and Lebanon, potentially escalating civilian casualties and international condemnation.

Share this article

Want the full story? Read the original reporting

Read on Al Jazeera